^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Bladder Cancer
    Drug:gemcitabine (DNA synthesis inhibitor) +
    ifosfamide (Bifunctional alkylating agent) +
    pegylated liposomal doxorubicin (Topoisomerase II inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Bladder cancer: Useful under certain circumstances…ifosfamide, doxorubicin, and gemcitabine...